These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17931098)

  • 1. Herbert Andre Fleisch, MD.
    Martin TJ; Bonjour JP; Russell RG
    J Bone Miner Res; 2007 Nov; 22(11):1651-3. PubMed ID: 17931098
    [No Abstract]   [Full Text] [Related]  

  • 2. Herbert Andre Fleisch, MD : 22 July 1933-15 May 2007.
    Martin TJ; Christiansen C; Kanis JA; Russell G
    Osteoporos Int; 2007 Aug; 18(8):1019-21. PubMed ID: 17598066
    [No Abstract]   [Full Text] [Related]  

  • 3. Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases.
    Francis MD; Valent DJ
    J Musculoskelet Neuronal Interact; 2007; 7(1):2-8. PubMed ID: 17396000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pamidronate and olpadronate discoverer, Prof. Olav Maria Leonard Bijvoet passed away].
    Roldán EJ
    Medicina (B Aires); 2014; 74(5):425-7. PubMed ID: 25347910
    [No Abstract]   [Full Text] [Related]  

  • 5. A tribute to Herbert Fleisch.
    Rizzoli R;
    Osteoporos Int; 2007 Sep; 18(9):1151. PubMed ID: 17609841
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development.
    Ruggiero SL
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):13-8. PubMed ID: 19371810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loving our bones.
    Sledge GW
    Clin Breast Cancer; 2009 May; 9(2):71. PubMed ID: 19433385
    [No Abstract]   [Full Text] [Related]  

  • 8. Resolution of bone lysis in Langerhans cell histiocytosis by bisphosphonate therapy.
    Tsuda H; Yamasaki H; Tsuji T
    Br J Haematol; 2011 Aug; 154(3):287. PubMed ID: 21595647
    [No Abstract]   [Full Text] [Related]  

  • 9. [Integrated supportive therapy for multiple myeloma-bone disease treatment, myeloma kidney treatment, cryotherapy, nutrition support team].
    Miwa A
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():603-27. PubMed ID: 23134022
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bisphosphonate treatment of osteoporosis and other skeletal diseases].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2011 Feb; 131(3):244-7. PubMed ID: 21304573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The return of phossy jaw?].
    Broome M; Jaques B; Madrid C
    Rev Stomatol Chir Maxillofac; 2008 Jun; 109(3):203-5. PubMed ID: 18533213
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of bisphosphonates for treating pathological states in orthopedics].
    Białecki P; Bohatyrewicz A; Machoy-Mokrzyńska A; Białecka M
    Chir Narzadow Ruchu Ortop Pol; 2008; 73(4):266-73. PubMed ID: 18847019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate treatment of pediatric bone disease.
    Speiser PW; Clarson CL; Eugster EA; Kemp SF; Radovick S; Rogol AD; Wilson TA;
    Pediatr Endocrinol Rev; 2005 Dec; 3(2):87-96. PubMed ID: 16361982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of skeletal-related events in patients with advanced prostate cancer treated with pamidronate or zoledronic acid.
    Spence MM; Hui RL; Chan J; Schottinger JE
    Ann Pharmacother; 2010 Sep; 44(9):1384-8. PubMed ID: 20682850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a review.
    Diel IJ
    Support Care Cancer; 2007 Nov; 15(11):1243. PubMed ID: 17393190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy and safety of bisphosphonate for patients with kidney disease].
    Hiramatsu R; Ubara Y
    Clin Calcium; 2016 Sep; 26(9):1319-24. PubMed ID: 27561347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Focus: Drug-related osteonecrosis of the jaw].
    Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
    Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition.
    Drake MT; Cremers SC
    Mol Interv; 2010 Jun; 10(3):141-52. PubMed ID: 20539033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid.
    Lein M; Miller K; Wirth M; Weissbach L; May C; Schmidt K; Haus U; Schrader M; Jung K
    Prostate; 2009 May; 69(6):624-32. PubMed ID: 19143027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The work of Andre Leri].
    Liévre JA
    Sem Hop; 1971 May; 47(25):1630-7. PubMed ID: 4327906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.